Evidence map›Paper›PMID 16896925›Full record

ArticleHuman genetics2006

Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5.

Courtney Gray-McGuire, Ritwik Sinha, Sudha Iyengar, Christopher Millard, Benjamin A Rybicki, Robert C Elston, Michael C Iannuzzi, SAGA Study Consortium

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Sarcoidosis Epidemiology: Race Matters.Frontiers in immunology · 2020
    Review
  4. Article
  5. Article
  6. Review
  7. Genetics of sarcoidosis: candidate genes and genome scans.Proceedings of the American Thoracic Society · 2007
    Review
  8. Genetic predisposition to respiratory diseases: infiltrative lung diseases.Respiration; international review of thoracic diseases · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Courtney Gray-McGuireDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA.
Ritwik Sinha
Sudha Iyengar
Christopher Millard
Benjamin A Rybicki
Robert C Elston
Michael C Iannuzzi
SAGA Study Consortium
Case Western Reserve University · USHenry Ford Health System · USMount Sinai Hospital · US

Funding

X-LINKED EXTENSION OF THE REVISED HASEMAN-ELSTON ALGORITHM FOR LINKAGE ANALYSISP41RR003655 · NCRR · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI ELSTON, ROBERT C. · 1987 to 2011
$11.5M
SARCOIDOSIS GENETIC LINKAGE CONSORTIUMU01HL060263 · NHLBI · HENRY FORD HEALTH SYSTEM · PI IANNUZZI, MICHAEL C · 1999 to 2003
$6.5M
GENETIC ANALYSIS OF MULTIFACTORIAL TRAITSR01GM028356 · NIGMS · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI ELSTON, ROBERT C. · 1985 to 1997
–
NCRR NIH HHS P41 RR003655NHLBI NIH HHS U01 HL060263NIGMS NIH HHS R01 GM28356
6 · The paper itself

Abstract

Sarcoidosis, a systemic granulomatous disease, likely results from both environmental agents and genetic susceptibility. Sarcoidosis is more prevalent in women and, in the United States, African Americans are both more commonly and more severely affected than Caucasians. We report a follow up of the first genome scan for sarcoidosis susceptibility genes in African Americans. Both the genome scan and the present study comprise 229 African American nuclear families ascertained through two or more sibs with sarcoidosis. Regions studied included those which reached a significance in the genome scan of 0.01 (2p25, 5q11, 5q35, 9q34, 11p15 and 20q13), 0.05 (3p25 and 5p15-13) or which replicated previous findings (3p14-11). We performed genotyping with additional markers in the same families used in the genome scan. We examined multi-locus models for epistasis and performed model-based linkage analysis on subsets of the most linked families to characterize the underlying genetic model. The strongest signal was at marker D5S407 (P=0.005) on 5q11.2, using both full and half sibling pairs. Our results support, in an African American population, a sarcoidosis susceptibility gene on chromosome 5q11.2, and a gene protective for sarcoidosis on 5p15.2. These fine mapping results further prioritize the importance of candidate regions on chromosomes 2p25, 3p25, 5q35, 9q34, 11p15 and 20q13 for African Americans. Additionally, our results suggest joint action of the effects of putative genes on chromosome 3p14-11 and 5p15.2. We conclude that multiple susceptibility loci for sarcoidosis exist in African Americans and that some may have interdependent effects on disease pathogenesis.

Indexed as

Chromosomes, Human, Pair 5Genetic Predisposition to DiseaseQuantitative Trait LociBlack or African AmericanChromosome MappingGene FrequencyGenetic LinkageHumansNuclear FamilySarcoidosis

Identifiers

PMID16896925
OpenAlexW2038165333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.